Clinical trial AMG420 -20160370
A Phase 1b/2 Multicenter, Open-label, Expansion Study to Assess the Safety and Efficacy of AMG 420 as Monotherapy in Subjects With Relapsed and/or Refractory Multiple Myeloma
Trial status | Trial closed for recruitment |
---|---|
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1/2 |
Academic trial | Non |
Sponsor | Amgen |
EudraCT Identifier | 2018-002879-17 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03836053 |
Last update |